Zenas BioPharma, Inc. (ZBIO)
NASDAQ · Healthcare
Zenas BioPharma, Inc. Operating Income 2023–2025
Zenas BioPharma, Inc. annual/quarterly operating income history and growth rate from 2023 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Zenas BioPharma, Inc. operating income for the quarter ending September 30, 2025 was -52.6 M, a 28.29% increase year-over-year.
- Zenas BioPharma, Inc. operating income for the twelve months ending September 30, 2025 was -186.1 M.
- Zenas BioPharma, Inc. annual operating income for 2025 was -383.1 M, a 133.73% increase from 2024.
- Zenas BioPharma, Inc. annual operating income for 2024 was -163.9 M, a 341.19% increase from 2023.
- Zenas BioPharma, Inc. annual operating income for 2023 was -37.1 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Zenas BioPharma, Inc. Operating Income — FAQ
Zenas BioPharma, Inc. (ZBIO) operating income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Zenas BioPharma, Inc.'s operating income?
Zenas BioPharma, Inc. (ZBIO) reported operating income of -$383M for fiscal 2025.
Where can I see ZBIO's operating income history?
The chart and table above show Zenas BioPharma, Inc.'s operating income by year and by quarter, including the growth rate.